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Introduction 
Recent reviews have described the potential adverse ef­
fects of obesity on quality of life (1,2). Impairments have 
been reported in physical functioning, including general 
health (3–6) and bodily pain (7), as well as in psychosocial 
status (8). In the latter domain, as many as 20% to 30% of 
individuals who seek weight reduction have been found to 
suffer from binge eating (9,10) or depression (11,12). 
Over the past 20 years, numerous instruments have been 
developed to assess quality of life (1,2,13,14). This article 
briefly reviews the meaning of this term and then examines 
measures that are likely to be the most useful with obese 
persons. Four sets of instruments are examined. The first 
consists of generic, broad-spectrum measures that assess 
multiple domains including physical, social, and vocational 
functioning. The second set consists of condition-specific 
measures that assess symptoms or experiences that are most 
likely to occur in patients with obesity (e.g., stigmatization, 
body image concerns, food preoccupation). The third and 
fourth sets of instruments assess depression and binge eat­
ing, respectively. We believe that these two complications 
should be evaluated, in addition to the more general con­
struct of quality of life. 
Health-Related Quality of Life 
Quality of life has become a buzz word in medicine, 
psychology, and society at large. The term is used to de­
scribe events that range from satisfaction with one’s work or 
leisure activities to the physical and economic burden im­
posed by specific illnesses (15). Katschnig (16) has aptly 
conveyed the breadth of this construct, defining quality of 
life as a “loosely related body of work on psychological 
well-being, social and emotional functioning, health status, 
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functional performance, life satisfaction, social support, and 
standard of living, whereby normative, objective, and sub­
jective indicators of physical, social and emotional func­
tioning are all used.” The present review focuses on health-
related quality of life (HRQOL). This domain typically 
assesses patients’ limitations in physical, emotional, social, 
or vocational functioning, using either general constructs or 
those developed to capture dysfunction associated with spe­
cific diseases. 
The HRQOL measures reviewed here were selected on 
the basis of their (1) relevance to obesity; (2) psychometric 
properties (i.e., high reliability and validity); (3) acceptance 
by researchers (i.e., widespread use); and (4) ease of ad­
ministration (i.e., low cost and patient/administrator bur­
dens). Although no instrument is ideal, there are several 
good options for use with obese individuals. 
Generic Measures of HRQOL 
Generic measures assess multiple domains of functioning 
including mobility, self-care, and physical, emotional, and 
social functioning. They may be used with a wide range of 
patient populations (17). These instruments allow investi­
gators to compare the degree of impairment or suffering 
associated with different illnesses, as well as relative im­
provements in functioning in response to treatment. They 
may, however, lack precision in measuring outcomes that 
are specific to the concerns of obese individuals (e.g., poor 
body image, food preoccupation). 
Medical Outcomes Study: Short Form-36. The most com­
monly used generic instrument is the Medical Outcomes 
Study questionnaire. It was originally developed to measure 
health outcomes as part of a 2-year observational study of 
more than 22,000 adults (18). The questionnaire was mod­
ified in 1989 (19) and again in 1992 to the current 36-item 
Short-Form General Health Survey (SF-36) (20). 
The SF-36 assesses eight health domains: 1) limitations 
in physical activities because of health problems; 2) reduc­
tions in usual role activities attributable to physical or 
emotional problems; 3) limitations in usual role activities 
because of physical health problems; 4) bodily pain; 5) 
general mental health (i.e., psychological distress and well­
Table 1. Reliability and validity of SF-36 scales 
Internal Test–retest 
Scale consistency reliability Validity 
Physical functioning 0.92 0.81 �0.63 
Role limitation 
(physical) 0.83 0.69 �0.46 
Pain 0.81 0.78 �0.59 
Social function 0.85 0.60 �0.67 
Role limitation 
(emotional) 0.83 0.63 0.38 
General health 0.79 0.80 0.45 
Vitality 0.87 0.80 0.45 
Mental health 0.90 0.75 0.60 
Internal consistency and reliability coefficients are based on gen­
eral practice patients in the United Kingdom (24). Validity coef­
ficients are in relation to a variety of quality of life measures (24).
 
Negative validity coefficients reflect scales that are scored in
 
opposite directions.
 
SF-36, short form-36.
 
being); 6) limitations in role activities because of emotional 
problems; 7) vitality (i.e., energy and fatigue); and 8) gen­
eral health perceptions (20). Six of the eight domains load 
on factors that assess either physical health (physical func­
tioning, physical role, and bodily pain) or behavioral health 
(mental health, emotional role, and social functioning) (21). 
Of the 36 items, 39% evaluate activity levels (22). Time for 
completing the questionnaire is 5 to 10 minutes. 
The SF-36 has well-established internal consistency, test– 
retest reliability, and validity (20,23) (see Table 1), as demon­
strated in a variety of patient populations throughout the world 
(24). In obese populations, increasing impairment (particularly 
on scales assessing physical dimensions; Table 2) has been 
reported with increasing weight (4,25–32). Improved function­
ing has been observed with weight loss (principally on scales 
assessing physical health) (28,33). Most studies of weight loss 
have been with surgical interventions (1,33,34), although 
investigations of lifestyle modification (7,35) and pharma­
cotherapy (36) have recently appeared. 
The Nottingham Health Profile. The Nottingham Health 
Profile (NHP) was developed in England in 1975, based on 
interviews with 768 patients with a variety of chronic med­
ical conditions. The current version was published in 1981 
(37). The instrument contains 45 subjective statements di­
vided into two parts. Part I includes 38 items that assess 
distress in the following six domains: 1) energy; 2) physical 
mobility; 3) emotional reaction; 4) pain; 5) sleep; and 6) 
social isolation. Part II assesses the degree to which health 
tion; 2) ability to perform jobs around the house; 3) social 
life; 4) home relationships; 5) sex life; 6) hobbies; and 7) 
holidays (29). The instrument takes 10 to 15 minutes to 
complete. 
The NHP has adequate internal consistency (�0.58) and 
strong validity (37–39). It has been translated into many 
languages (38,40 –43) and used in diverse medical and 
patient populations (38,39). The NHP has not been widely 
used with obese individuals, although two studies found 
improvements on the scale after surgically induced weight 
loss (44,45). The instrument seems to capture treatment-
related changes with other medical conditions (38,39). 
The Sickness Impact Profile. The Sickness Impact Profile 
(SIP) is a 136-item general health status questionnaire that 
is widely used in the United States and Europe (46 –48). It 
emphasizes observable behavior (e.g., “I sit during much of 
the day”) and does not contain subjective evaluations of 
well-being. The SIP measures two primary dimensions: 
physical functioning (body care and movement, walking, 
and mobility) and psychosocial functioning (emotional be­
havior, social interaction, alertness behavior, and commu­
nication). It requires �30 minutes to complete. Therefore, it 
is more burdensome to patients than the previously de­
scribed instruments. Although a shorter 68-item version of 
the SIP has been constructed (49,50), it is not yet widely 
used and awaits further validation. 
The SIP has strong internal consistency and test-retest 
reliability (r � 0.81 to 0.97), but only modest criterion 
validity with other clinical measures of disease (r � 0.38 to 
0.48) (46). It has been translated into several languages 
and used in a variety of medical populations (51). As with 
the NHP, few studies have used the SIP with obese indi­
viduals (52,53). 
Obesity-Specific Measures of HRQOL 
In contrast to generic measures, condition-specific instru­
ments are designed to capture symptoms or experiences 
associated with a specific disorder. There are, for example, 
quality of life instruments designed specifically for patients 
with diabetes (54), arthritis (55), and asthma (56), to name 
but a few. Several instruments have been developed for 
obesity (3–6,57–59). An obesity-specific measure has the 
potential advantage of capturing experiences that are fre­
quently reported by obese individuals, such as feeling so­
cially uncomfortable when swimming in public, shopping 
for clothes, or applying for a job. Such experiences are not 
assessed by generic measures of HRQOL or by mood in­
ventories. In addition, condition-specific measures tend to 
be more sensitive to change than are generic measures 
(60,61). The main disadvantage of obesity-specific instru­
ments is their limited empirical validation, which is due 
primarily to their having been only recently developed, and 
problems affect the following seven domains: 1) occupa- thus, not widely used. 
Table 2. SF-36 scales 
No. of 
Concepts items Range of functioning 
Physical functioning 10 
Role-physical 4 
Bodily pain 2 
General health 5 
Vitality 4 
Social functioning 2 
Role-emotional 3 
Mental health 5 
Reported health 1 
transition 
Adapted from Ware and Sherbourne (20). 
SF-36, short form-36. 
Limited a lot in performing all physical 
activities including bathing or 
dressing due to health 
Problems with work or other daily 
activities as a result of physical 
health 
Very severe and extremely limiting pain 
Evaluates personal health as poor and 
believes it is likely to get worse 
Feels tired and worn out all of the time 
Extreme and frequent interference with 
normal social activities due to 
physical or emotional problems 
Problems with work or other daily 
activities as a result of emotional 
problems 
Feelings of nervousness and depression 
all of the time 
Believes general health is much worse 
now than one year ago 
Performs all types of physical 
activities including the most 
vigorous without limitation due to 
health 
No problems with work or other 
daily activities as a result of 
physical health 
No pain or limitation due to pain 
Evaluates personal health as excellent 
Feels full of pep and energy all of 
the time 
Performs normal social activities with 
out interference due to physical or 
emotional problems 
No problems with work or other 
daily activities as a result of 
emotional problems 
Feels peaceful, happy, and calm all 
of the time 
Believes general health is much 
better now than one year ago 
Impact of Weight on Quality of Life Questionnaire. The 
Impact of Weight on Quality of Life Questionnaire 
(IWQOL) is a 74-item self-report measure that requires 
�15 minutes to complete (5). The instrument asks respon­
dents to describe the effects that their weight has on their 
functioning in eight areas including 1) health; 2) social/ 
interpersonal status; 3) work; 4) mobility; 5) self-esteem; 6) 
sex; 7) activities of daily living; and 8) eating. A new 
31-item version of the questionnaire assesses function in 
five areas (i.e., physical function, self-esteem, sexual life, 
public distress, and work) (62). Preliminary data indicate 
that both the long (5,63) and short (62,64,65) versions of the 
questionnaire have good test–retest reliability and internal 
consistency. Both questionnaires also revealed significant 
improvements in all domains of functioning with weight 
reduction (62–64). 
The IWQOL includes scales that capture experiences that 
are specific to obese individuals. Examples include: “Be-
and “Because of my weight, I am self-conscious.” Potential 
drawbacks of the IWQOL include uncertainty concerning 
the clinical significance of the complaints reported. Data, 
for example, are needed to indicate the level at which 
problems with self-esteem or eating behavior meet criteria 
for established behavioral disorders, as described in the 
Diagnostic and Statistical Manual of Mental Disorders, 
Fourth edition (66). Such data would help practitioners 
distinguish experiences that may detract from optimal hap­
piness or functioning from those that truly impair social, 
vocational, or mental status. Data are also needed to deter­
mine what constitutes a clinically significant change in 
function in each domain, and the relative contribution of 
each domain to overall functioning. Finally, the IWQOL 
asks participants to report the occurrence of negative or 
adverse experiences and to infer the cause of these experi­
ences, as suggested by the wording, “Because of my weight, 
I . . .” It would be useful to compare responses to the in-
cause of my weight, I experience discrimination by others,” strument with and without the inclusion of this inference. 
Obesity-Related Problem Scale. The Obesity-Related 
Problem Scale (OP) is a brief condition-specific measure 
that was designed for the Swedish Obese Subjects (SOS) 
study. This investigation is evaluating the long-term effects 
of weight loss (achieved by bariatric surgery or conven­
tional dieting) on changes in physical and psychosocial 
health (58). As described by its authors, the OP measures 
the effects of obesity on psychosocial functioning in every­
day life (58). The 8-item scale asks respondents how both­
ered they are by their obesity in relation to going to a party, 
going to restaurants or community activities, taking a vaca­
tion, trying on and buying clothes, swimming in public 
places, and having intimate relations. 
The OP is psychometrically valid (67) and seems to be 
responsive to weight reduction in both surgically and con­
ventionally treated patients (58,67). The SOS study found a 
dose-response relationship between weight loss and changes 
in OP scale scores (i.e., the more weight loss, the greater 
the reduction of obesity-related psychosocial problems) 
(13,67). The scale, however, has not been widely used 
outside of the SOS study, and convergent and discriminant 
validity have yet to be determined. As with the IWQOL 
described above, it also is difficult with the OP to determine 
the clinical significance of the complaints reported or of 
the improvements in functioning that may occur with 
weight loss. 
Summary Evaluation and Recommendation 
In summary, the SF-36, NHP, and SIP have acceptable 
psychometric properties and have been standardized on 
diverse populations. They all measure physical and social 
domains, and the SF-36 and NHP also assess subjective 
factors. The SF-36 is recommended for a short yet compre­
hensive measure of HRQOL. It is the least burdensome for 
respondents and is easy to administer. It has extensive 
psychometric validation and has been normed by age and 
gender for the United States and other populations. Its scales 
are responsive to treatment of numerous medical conditions, 
including obesity. In addition, the SF-36 will allow re­
searchers to compare the burdens imposed by obesity with 
those associated with other disorders. For investigators who 
desire an obesity-specific measure of quality of life, we 
recommend the IWQOL, with the qualifications noted. The 
OP may be useful but needs further investigation in a 
broader sample of overweight and obese individuals (rather 
than simply those eligible for bariatric surgery). 
Mood and Binge Eating 
The SF-36 contains a measure of general mental health. If 
patients score within normal limits on this scale, further 
assessment may not be necessary. However, given the in­
creased prevalence of dysthymia and depression in obese 
ularly among the severely obese (69), we believe it is 
appropriate to assess mood more fully. Similarly, patients 
should be evaluated for the presence of an eating disorder, 
a domain that it is not covered by the SF-36 or any other 
general measures of quality of life. 
Mood 
Early population studies generally found few significant 
differences in psychopathology between obese and non-
obese individuals (12). However, a recent well-designed 
investigation showed that excess weight in women was 
associated with an increased risk of major depression, sui­
cide attempts, and suicidal ideation (71). (Surprisingly, in 
men the inverse was found; excess weight was associated 
with a decreased risk of depression and suicidality.) In­
creased levels of depression and other psychopathology are 
common in obese men and women who seek weight-loss 
treatment (11,72). 
The Beck Depression Inventory-II (BDI-II) (73) is a 
21-item questionnaire that measures specific symptoms of 
depression. It is easy to complete (in �5 minutes), score, 
and interpret, and its internal consistency, test–retest reli­
ability, and validity are well established (73). Other mea­
sures of depression are available, including the Hamilton 
Rating Scale for Depression (74) and the Center for Epide­
miological Studies measure of Depression (75). However, 
we recommend the BDI-II because of its widespread use 
and minimal inclusion of items biased by obesity. The 
BDI-II has been used extensively with obese individuals 
and is responsive to both weight reduction (76,77) and 
cognitive interventions (78). 
Eating Disorders 
Approximately 20% to 30% of obese individuals who 
seek weight loss report problems with binge eating 
(9,10,79), usually in association with a depressed mood or 
related complications (9,80–84). Binge-eating disorder 
(BED) is characterized by the consumption of large 
amounts of food in a discrete period of time and by the 
patient’s report of loss of control during the episode. The 
overeating is not followed by compensatory behaviors (such 
as vomiting or laxative abuse), thus distinguishing BED 
from bulimia nervosa. Marked distress must occur in at least 
three areas, including eating very rapidly, eating until un­
comfortably full, eating when not hungry, eating alone, or 
feeling guilty after a binge (66). Binge eating is a reliable 
marker of symptoms of depression. By contrast, multiple 
studies have shown that mood is essentially normal in obese 
individuals who do not suffer from binge eating (68). 
At least three self-administered questionnaires are cur­
rently used to assess BED. The Questionnaire on Eating and 
Weight Patterns-Revised (QEWP-R) (9,10) is a 28-item 
instrument that provides decision rules for diagnosing BED, 
individuals who seek weight reduction (12,68 –70), partic- bulimia nervosa, and related eating disorders. It has been 
found to have adequate validity and reliability (9). The 
principal drawback of the QEWP-R is that diagnosis should 
be confirmed by a brief interview. Alternatively, the Binge 
Eating Scale (BES) (85) is an easily administered 16-item 
questionnaire that assesses symptoms of binge eating. The 
scale has adequate internal consistency and validity (85). 
The BES, however, was developed before the introduction 
of criteria for BED, and the scale does not include several 
items needed to diagnose this condition. The BES and 
QEWP-R are only moderately correlated (� � 0.58) (86). 
A third option is the Eating Disorder Examination Ques­
tionnaire (EDE-Q) (87), a self-report version of the 30- to 
60-minute structured interview developed by Cooper and 
Fairburn (88) to assess bulimia nervosa and related disor­
ders, including BED. The validity of the EDE-Q for diag­
nosing BED in obese individuals is still being determined 
(89–91). If favorable results are obtained, this may be the 
preferred instrument because, in addition to yielding diag­
noses, it includes subscales that measure dietary restraint, 
shape concerns, and related variables. However, until addi­
tional data are available, we recommend the use of the 
QEWP-R in conjunction with a 5- to 10-minute interview. 
The interview allows the practitioner to confirm that pa­
tients who report binge eating, in fact, routinely eat an 
objectively large amount of food and experience loss of 
control. The QEWP-R and self-report questionnaires, in 
general, may overestimate the frequency of binge episodes 
(92). The interview serves, in part, to address this limitation. 
Summary 
To assess the impact of obesity on general quality of life, 
we recommend the SF-36 because of its brevity, ease of 
administration and coverage of both physical and psycho­
social domains. In addition, it provides norms for numerous 
age groups and patient populations. We also recommend the 
use of the BDI-II and QEWP-R to assess depression and 
binge eating, respectively. These latter complications are 
frequently observed in obese patients who seek treatment. 
Current findings indicate that a substantial portion of 
obese individuals in the general population experience un­
desired physical or social consequences of their weight that 
diminish their quality of life in one or more areas (68,70). 
These complications typically do not require professional 
attention, but nevertheless, are likely to detract from the 
individual’s optimal enjoyment of work and leisure activi­
ties. Further research is needed to identify those individuals 
who are at greatest risk of progressing from decreased 
quality of life to clinically significant impairment in phys­
ical, social, vocational, or mental status. We believe these 
individuals are most likely to be encountered in clinical 
settings and to have a body mass index �40 kg/m2 (11,69). 
It is imperative that they receive appropriate medical 
and behavioral care, independent of their desire or ability to 
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